PRESS RELEASE
News
-
-
PRESS RELEASE
Helvetica Swiss Commercial Fund convainc au premier semestre 2025 par un solide revenu net, une performance supérieure à l’indice de référence et une fusion réussie des fonds
Le Helvetica Swiss Commercial Fund affiche un solide revenu net et une performance supérieure au premier semestre 2025, avec fusion réussie des fonds -
-
PRESS RELEASE
EQS-Adhoc: Heidelberg Pharma’s Partner Telix Pharmaceuticals Gives Regulatory Update for its Imaging Agent TLX250-CDx
Heidelberg Pharma's partner Telix Pharmaceuticals faces delays in TLX250-CDx FDA approval. USD 70 million payment from HealthCare Royalty postponed. Current cash reach until Q1 2026 -
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Delivery Hero SE updates FY 2025 guidance to reflect foreign exchange rate headwinds, now expecting lower adjusted EBITDA and Free Cash Flow
Delivery Hero SE updates FY 2025 guidance due to foreign exchange rate headwinds, expecting lower adjusted EBITDA and Free Cash Flow. Details on GMV, Segment Revenue, and impact discussed
